RxDoctor Payments Data

Kristen Fregoso, PA

Medical · North Chicago, ILNPI 1730639451

Payments from drug & device makers

$1,371in general payments, 2019–2025

Across 86 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$365
  • Novo Nordisk$312
  • AbbVie$140
  • AstraZeneca$114
  • Pfizer$93
  • Exact Sciences$75
  • plus $271 from 8 others

What the payments were for

  • Food & beverage$1,371100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,371 in reported general payments places this provider in the 70th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois

Medicare billing

Part B allowed, 2024
$39,584
Medicare patients
173
Services billed
752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide77$80,679
EliquisApixaban57$60,750
MounjaroTirzepatide43$44,003
JardianceEmpagliflozin33$40,055
RybelsusSemaglutide30$36,023
TrulicityDulaglutide16$32,196
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$28,339
Tresiba Flextouch U-100Insulin Degludec28$21,611
WegovySemaglutide11$14,030
XareltoRivaroxaban13$11,497
Breo ElliptaFluticasone/Vilanterol17$8,131
Spiriva RespimatTiotropium Bromide14$7,066
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$4,943
Dexlansoprazole DrDexlansoprazole17$4,445
Omeprazole347$3,832

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Wegovy$312$130,732118 claims
Lilly USA, LLCMounjaro, Trulicity$365$76,20059 claims
PfizerEliquis, Paxlovid$93$63,67676 claims
AstraZenecaSymbicort$114$2,45311 claims
AbbVieSynthroid$140$2,23428 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 449 medical providers in Illinois.

Other medical in North Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →